Revolutionizing head and neck squamous cell carcinoma treatment with nanomedicine in the era of immunotherapy

Revolutionizing head and neck squamous cell carcinoma treatment with nanomedicine in the era of immunotherapy

Head and neck squamous cell carcinoma (HNSCC) is a prevalent malignant tumor globally. Despite advancements in treatment methods, the overall survival rate remains low due to limitations such as poor targeting and low bioavailability, which result in the limited efficacy of traditional drug therapie...

Full description

Saved in:
Bibliographic Details
Main Authors: Hong-Xia Li, Yu-Wen Gong, Pi-Jun Yan, Yong Xu, Gang Qin, Wei-Ping Wen, Fang-Yuan Teng
Format: Article
Language:English
Published: Frontiers Media S.A. 2024-11-01
Series:Frontiers in Immunology
Subjects:
head and neck squamous cell carcinoma
nanomedicine
treatment
tumor microenvironment
drug delivery
Online Access:https://www.frontiersin.org/articles/10.3389/fimmu.2024.1453753/full
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items